Healthcare & Life Sciences
Algiax
Germanyalgiax.com
Algiax is a Healthcare & Life Sciences startup based in Germany, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
2011
Founded
1
Investors
About Algiax
Algiax is a company founded in 2011 headquartered in Germany. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Algiax is a clinical-stage biotech company developing AP-325 to treat peripheral post-surgical neuropathic pain; its Phase 2 study reported meaningful pain reduction with fewer side effects. The company focuses on developing novel therapeutics for neuropathic pain.
Explore Algiax's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.